JS
Jatinbhai Siddharthbhai Shah
About Jatinbhai Siddharthbhai Shah
Data last updated:
Jatinbhai Siddharthbhai Shah is a Director at Rampex Labs Private Limited (since 2021), Director at Espee Lifesciences Private Limited (since 2009) and Director at Gliesse Pharmaceuticals Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Pharma, Chemicals and Materials and Biotechnology. The 4 current companies with reported revenue have a combined latest revenue of ₹171 Cr; the largest is Rampex Labs Private Limited at ₹153 Cr (FY 2025). Earlier, Jatinbhai Siddharthbhai Shah was a Director at Healthy Life Nutraceuticals Private Limited (2012–2014) and Director at Relius Lifesciences Private Limited (2016–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Sep 2021 | 2004 | ₹153 Cr (FY 2025) | Active | |
| Director | 23 Sep 2009 | 2009 | ₹8.00 Cr (FY 2025) | Active | |
| Director | 08 Aug 2020 | 2020 | ₹6.78 Cr (FY 2025) | Active | |
| Director | 25 Sep 2019 | 2019 | ₹3.14 Cr (FY 2024) | Active | |
| Director | 12 Dec 2024 | 2024 | Active | ||
| Director | 09 Jan 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jun 2012 | 2012 | Converted To Llp | ||
| Director | 21 Nov 2016 | 2016 | Active | ||
| Designated Partner | 12 Feb 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jatinbhai Siddharthbhai Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jatinbhai Siddharthbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jatinbhai Siddharthbhai Shah
Jatinbhai Siddharthbhai Shah currently holds 6 directorships: Rampex Labs Private Limited (Director, since 02 Sep 2021, revenue ₹153 Cr (FY 2025)); Espee Lifesciences Private Limited (Director, since 23 Sep 2009, revenue ₹8.00 Cr (FY 2025)); Gliesse Pharmaceuticals Private Limited (Director, since 08 Aug 2020, revenue ₹6.78 Cr (FY 2025)); Espee International Finechempharma Private Limited (Director, since 25 Sep 2019, revenue ₹3.14 Cr (FY 2024)); Biovex Lifesciences Private Limited (Director, since 12 Dec 2024); and 1 more.
Jatinbhai Siddharthbhai Shah was first appointed on 23 Sep 2009 as Director at Espee Lifesciences Private Limited. The most recent appointment on record is 12 Dec 2024 at Biovex Lifesciences Private Limited.
The 4 current companies of Jatinbhai Siddharthbhai Shah that report revenue have a combined latest revenue of ₹171 Cr: Rampex Labs Private Limited ₹153 Cr (FY 2025); Espee Lifesciences Private Limited ₹8.00 Cr (FY 2025); Gliesse Pharmaceuticals Private Limited ₹6.78 Cr (FY 2025); Espee International Finechempharma Private Limited ₹3.14 Cr (FY 2024).
Jatinbhai Siddharthbhai Shah held 3 earlier board appointments: Healthy Life Nutraceuticals Private Limited (Director, 21 Jun 2012 to 25 Jul 2014); Relius Lifesciences Private Limited (Director, 21 Nov 2016 to 17 Mar 2020); Seven Shores Management Services Llp (Designated Partner, from 12 Feb 2015).
The current boards of Jatinbhai Siddharthbhai Shah's companies include Gorrepati Ranga N B (Rampex Labs Private Limited), Lokanath Bolleni (Rampex Labs Private Limited), Maganti Murali (Rampex Labs Private Limited), Nishant Tiwary (Rampex Labs Private Limited), Shivani (Rampex Labs Private Limited), Surya Venkata Narasimha Sastry Jayanty (Rampex Labs Private Limited), among others.